Stereotaxis Inc Stock Nasdaq
Stocks
US85916J4094
Advanced Medical Equipment & Technology
| Market Cap | 126M 109M 102M 93.26M 176M 11.98B 179M 1.2B 470M 5.97B 471M 461M 20B | P/E 2026 * |
-6.3x | P/E 2027 * | -8.4x |
|---|---|---|---|---|---|
| Enterprise Value | 126M 109M 102M 93.26M 176M 11.98B 179M 1.2B 470M 5.97B 471M 461M 20B | EV / Sales 2026 * |
3.19x | EV / Sales 2027 * | 2.36x |
| Free-Float |
84.7% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Stereotaxis Inc
| 1 day | -7.43% |
| Manager | Title | Age | Since |
|---|---|---|---|
David Fischel
CEO | Chief Executive Officer | - | 03/02/2017 |
Kimberly Peery
DFI | Director of Finance/CFO | 57 | 01/10/2019 |
Keith Galloway
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
David Benfer
BRD | Director/Board Member | 79 | 01/02/2005 |
David Fischel
CHM | Chairman | - | 03/02/2017 |
Arun Menawat
BRD | Director/Board Member | 71 | 29/09/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -7.43% | -2.84% | - | - | 126M | |
| -0.43% | +1.06% | +24.03% | +3.71% | 212B | |
| -0.61% | +1.82% | -1.07% | -24.39% | 137B | |
| +0.10% | +4.69% | -26.86% | +12.57% | 125B | |
| +1.59% | +5.60% | -55.67% | -7.68% | 69.46B | |
| -0.98% | +4.16% | +8.50% | +7.08% | 49.56B | |
| +6.54% | +7.82% | -17.08% | -20.95% | 47.2B | |
| -0.25% | -0.14% | +21.91% | +8.35% | 39.08B | |
| -0.79% | +0.70% | +29.97% | +29.32% | 37.05B | |
| +0.00% | +5.67% | +116.67% | +8.20% | 30.97B | |
| Average | -0.19% | +3.19% | +11.15% | +1.80% | 83.06B | |
| Weighted average by Cap. | +0.41% | +2.80% | +3.92% | -0.66% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 39.4M 34.25M 31.88M 29.27M 55.27M 3.76B 56.13M 376M 147M 1.87B 148M 145M 6.28B | 53.28M 46.31M 43.11M 39.58M 74.74M 5.09B 75.9M 508M 199M 2.53B 200M 196M 8.49B |
| Net income | -19.4M -16.86M -15.7M -14.41M -27.22M -1.85B -27.64M -185M -72.62M -922M -72.86M -71.26M -3.09B | -13.62M -11.84M -11.02M -10.12M -19.11M -1.3B -19.41M -130M -51M -648M -51.17M -50.05M -2.17B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
